WALLIX GROUP (ALLIX.PA) Fundamental Analysis & Valuation

EPA:ALLIX • FR0010131409

23 EUR
-0.95 (-3.97%)
Last: Mar 6, 2026, 07:00 PM

This ALLIX.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Overall ALLIX gets a fundamental rating of 2 out of 10. We evaluated ALLIX against 121 industry peers in the Software industry. Both the profitability and financial health of ALLIX have multiple concerns. ALLIX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. ALLIX.PA Profitability Analysis

1.1 Basic Checks

  • ALLIX had negative earnings in the past year.
  • ALLIX had a positive operating cash flow in the past year.
  • In the past 5 years ALLIX always reported negative net income.
  • In multiple years ALLIX reported negative operating cash flow during the last 5 years.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

  • The Return On Assets of ALLIX (-3.54%) is worse than 71.07% of its industry peers.
  • ALLIX has a worse Return On Equity (-24.53%) than 80.99% of its industry peers.
Industry RankSector Rank
ROA -3.54%
ROE -24.53%
ROIC N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40 -50

1.3 Margins

  • With an excellent Gross Margin value of 114.69%, ALLIX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • ALLIX's Gross Margin has been stable in the last couple of years.
  • ALLIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 114.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100

0

2. ALLIX.PA Health Analysis

2.1 Basic Checks

  • ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALLIX has a better debt/assets ratio than last year.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of 1.23, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
  • ALLIX's Altman-Z score of 1.23 is on the low side compared to the rest of the industry. ALLIX is outperformed by 66.12% of its industry peers.
  • ALLIX has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • ALLIX has a Debt to Equity ratio of 1.07. This is amonst the worse of the industry: ALLIX underperforms 83.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACCN/A
WACC8.46%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • ALLIX has a Current Ratio of 0.81. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALLIX has a worse Current ratio (0.81) than 86.78% of its industry peers.
  • ALLIX has a Quick Ratio of 0.81. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.81, ALLIX is doing worse than 85.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.81
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

6

3. ALLIX.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 79.48% over the past year.
  • ALLIX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.72%.
  • The Revenue has been growing by 15.85% on average over the past years. This is quite good.
EPS 1Y (TTM)79.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.55%
Revenue 1Y (TTM)17.72%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%18.89%

3.2 Future

  • The Earnings Per Share is expected to grow by 62.35% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 22.11% on average over the next years. This is a very strong growth
EPS Next Y102.6%
EPS Next 2Y74.7%
EPS Next 3Y62.35%
EPS Next 5YN/A
Revenue Next Year19.82%
Revenue Next 2Y21.78%
Revenue Next 3Y22.11%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

2

4. ALLIX.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALLIX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 27.57, the valuation of ALLIX can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ALLIX is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 24.60. ALLIX is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 27.57
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALLIX indicates a slightly more expensive valuation: ALLIX is more expensive than 65.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.75
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

  • ALLIX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 62.35% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.7%
EPS Next 3Y62.35%

0

5. ALLIX.PA Dividend Analysis

5.1 Amount

  • No dividends for ALLIX!.
Industry RankSector Rank
Dividend Yield 0%

ALLIX.PA Fundamentals: All Metrics, Ratios and Statistics

WALLIX GROUP

EPA:ALLIX (3/6/2026, 7:00:00 PM)

23

-0.95 (-3.97%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-03
Earnings (Next)03-19
Inst Owners13.23%
Inst Owner ChangeN/A
Ins Owners19.72%
Ins Owner ChangeN/A
Market Cap155.02M
Revenue(TTM)36.95M
Net Income(TTM)-1.80M
Analysts84
Price Target34.17 (48.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.84%
PT rev (3m)9.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-20%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)-1.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 27.57
P/S 4.2
P/FCF N/A
P/OCF 37.53
P/B 21.15
P/tB N/A
EV/EBITDA 48.75
EPS(TTM)-0.28
EYN/A
EPS(NY)0.83
Fwd EY3.63%
FCF(TTM)-0.42
FCFYN/A
OCF(TTM)0.61
OCFY2.66%
SpS5.48
BVpS1.09
TBVpS-1.98
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.54%
ROE -24.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 114.69%
FCFM N/A
ROA(3y)-11.42%
ROA(5y)-10.74%
ROE(3y)-44.79%
ROE(5y)-35.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.14%
GM growth 5Y-0.06%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Debt/EBITDA 2.36
Cap/Depr 121.53%
Cap/Sales 18.87%
Interest Coverage N/A
Cash Conversion 124.2%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.81
Altman-Z 1.23
F-Score6
WACC8.46%
ROIC/WACCN/A
Cap/Depr(3y)134.63%
Cap/Depr(5y)153.59%
Cap/Sales(3y)19.11%
Cap/Sales(5y)22.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.55%
EPS Next Y102.6%
EPS Next 2Y74.7%
EPS Next 3Y62.35%
EPS Next 5YN/A
Revenue 1Y (TTM)17.72%
Revenue growth 3Y13.73%
Revenue growth 5Y15.85%
Sales Q2Q%18.89%
Revenue Next Year19.82%
Revenue Next 2Y21.78%
Revenue Next 3Y22.11%
Revenue Next 5YN/A
EBIT growth 1Y75.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.88%
EBIT Next 3Y66.73%
EBIT Next 5YN/A
FCF growth 1Y50.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y549.02%
OCF growth 3Y-37.14%
OCF growth 5YN/A

WALLIX GROUP / ALLIX.PA FAQ

What is the ChartMill fundamental rating of WALLIX GROUP (ALLIX.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALLIX.PA.


What is the valuation status for ALLIX stock?

ChartMill assigns a valuation rating of 2 / 10 to WALLIX GROUP (ALLIX.PA). This can be considered as Overvalued.


What is the profitability of ALLIX stock?

WALLIX GROUP (ALLIX.PA) has a profitability rating of 2 / 10.